| abstract |
This invention relates to novel lactams having Formula (I) to their pharmaceutical compositions and to their methods of use. These novel compoun ds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of A.beta.-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, th e present invention relates to the treatment of neurological disorders related to .beta.-amyloid production such as Alzheimer's disease and Down's Syndrome . |